Literature DB >> 18473879

Differentiation of osteoblasts and osteocytes from mesenchymal stem cells.

Terhi J Heino1, Teuvo A Hentunen.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent cells that arise from the mesenchyme during development. They reside in the bone marrow close to hematopoietic stem cell niches allowing them to maintain bone marrow homeostasis and to regulate the maturation of both hematopoietic and non-hematopoietic cells. MSCs possess an extensive potential to proliferate and differentiate e.g. into osteoblasts, osteocytes, adipocytes and chondrocytes. Nevertheless, there still are some open questions about the complex process of MSC differentiation involving different transcription factors and signaling pathways, which will be discussed in this review. We also shortly introduce the characteristics and function of bone-forming osteoblasts and their role in angiogenesis. MSCs are of interest in clinical applications, since they can be easily isolated from bone marrow aspirates and expanded in vitro. When the source of osteoprogenitors is compromised, cell-based therapies could provide a novel way to repair bone defects. Indeed, there is an increasing interest in the use of MSCs and more differentiated cells in clinical applications for bone repair, which will be introduced in this review. A major section of the review is dedicated to the functions of osteocytes in the regulation of bone remodeling. Finally, we present an original hypothesis about the possible role of osteocytes in future bone tissue engineering.

Entities:  

Mesh:

Year:  2008        PMID: 18473879     DOI: 10.2174/157488808784223032

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  64 in total

1.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Authors:  Ulrich Lindner; Jan Kramer; Jürgen Rohwedel; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

2.  Foxc2 over-expression in bone marrow mesenchymal stem cells stimulates osteogenic differentiation and inhibits adipogenic differentiation.

Authors:  Wulin You; Lihong Fan; Dapeng Duan; Lei Tian; Xiaoqian Dang; Chunsheng Wang; Kunzheng Wang
Journal:  Mol Cell Biochem       Date:  2014-01       Impact factor: 3.396

3.  Correlating the effects of bone morphogenic protein to secreted soluble factors from fibroblasts and mesenchymal stem cells in regulating regenerative processes in vitro.

Authors:  Kristen M Lynch; Tabassum Ahsan
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

4.  Differential expression of long noncoding ribonucleic acids during osteogenic differentiation of human bone marrow mesenchymal stem cells.

Authors:  Liang Wang; Yipeng Wang; Zhengyao Li; Ziquan Li; Bin Yu
Journal:  Int Orthop       Date:  2015-01-30       Impact factor: 3.075

5.  Magnetically labeled mesenchymal stem cells after autologous transplantation into acutely injured liver.

Authors:  Xiao-Lei Shi; Jin-Yang Gu; Bing Han; Hai-Yun Xu; Liang Fang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

6.  E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα.

Authors:  Lei Zhang; Qian Zhou; Ning Zhang; Weixu Li; Meidan Ying; Wanjing Ding; Bo Yang; Qiaojun He
Journal:  Cell Cycle       Date:  2014-02-17       Impact factor: 4.534

7.  MicroRNA profiles of BMSCs induced into osteoblasts with osteoinductive medium.

Authors:  Zhixiong Yan; Yong Guo; Yang Wang; Yanan Li; Jiahui Wang
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

Review 8.  Semaphorin 3A: A new player in bone remodeling.

Authors:  Ren Xu
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

9.  Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.

Authors:  Sheik Wisel; Mahmood Khan; M Lakshmi Kuppusamy; I Krishna Mohan; Simi M Chacko; Brian K Rivera; Benjamin C Sun; Kálmán Hideg; Periannan Kuppusamy
Journal:  J Pharmacol Exp Ther       Date:  2009-02-13       Impact factor: 4.030

10.  Rough titanium alloys regulate osteoblast production of angiogenic factors.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Rolando A Gittens; Jennifer M Schneider; David A Haithcock; Peter F Ullrich; Paul J Slosar; Zvi Schwartz; Barbara D Boyan
Journal:  Spine J       Date:  2013-05-14       Impact factor: 4.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.